GL1X · GenesisL1 explorer

MolNFT v1 · #169447 · protein

Crystal structure of an anti-SARS-cov-2 human neutralizing antibody Fab fragment, C105

6XCA · C105 heavy chain: “Crystal structure of an anti-SARS-cov-2 human neutralizing antibody Fab fragment, C105”. X-ray diffraction, 1 ligand (SO4), 2 pockets (best druggability 0.48). MolNFT v1 #169447 on GenesisL1: 3D structure, binding…

PDB
6XCA
Type
protein
Length
422 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C105 heavy chain; C105 light chain
Ligands
SO4
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HC105 heavy chainprotein2119% helix, 51% strand—
LC105 light chainprotein2117% helix, 50% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12410.480.7431empty
2510.290.7511empty

Interfaces

1 interface between chains.

  • H–L · 1701 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6XCA · Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C105 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.